ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, CIB1, BRCA1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PNKP, COPS7A, RAD51AP1, TFPT, FZR1, POLR2B, RAD21, RAD54L, POLR2G, USP51, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, UBE2T, POLE2, CDK2, ERCC5]
GO:0036376;sodium ion export across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;131.16583792001737;7.138016298065211;0.004390002553592762;0.7612791106150483;[ATP1B2]
GO:0015793;glycerol transport;7.0;1.0;0.8509193652572005;9.628524252492122;38.31975435487899;7.9853141584524145;0.0012825276927178712;0.7592887026755414;[AQP1]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[EIF4A3, CIB1, BPTF]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[MAP3K3, XBP1, SPHK1, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, RRAS, SP1, TBXA2R, CTSH, EPHA1]
GO:0034628;'de novo' NAD biosynthetic process from aspartate;13.0;1.0;0.9625549647676366;9.628524252492122;3848.6070510476884;8.67846133901236;0.12880941447709104;0.9063718812344532;[NMNAT3]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ELL, UBE2B, RIC8A, FLCN, CCNB1, RXRA, ALS2, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SOX6, SEC24C]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, CKS1B, FLCN, NIPBL, LBH, NUP62, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, TFDP1, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1]
GO:0072189;ureter development;4.0;1.0;0.75;9.628524252492122;30.207912033305377;8.390779266560578;0.0010110316303989237;0.6791048419030481;[NFIA]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[ITLN1, PKD2L1, CLYBL]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[AQP1]
GO:0035435;phosphate ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;110.11210983553856;7.138016298065211;0.003685353221730381;0.7400384854347593;[SLC25A3, SLC37A1, ANKH, SLC20A1, SLC25A10]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, FGG, RIPK1, TNFRSF10A, BRCA1, RFFL]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK6, KCND1, SLC9A6, KCNK12, PKD2L1, ATP1B2, KCNK3, AQP1]
GO:1902041;regulation of extrinsic apoptotic signaling pathway via death domain receptors;9.0;0.8259837884571596;0.8092325194088689;9.485423408851448;64.8607677845634;5.734022359845919;0.0021708315268480906;0.6894787953221185;[FGA, SFRP1, FEM1B, FGG, RIPK1, TNFRSF10A, BRCA1, RFFL, THBS1, STK3]
GO:0090344;negative regulation of cell aging;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;80.6841056931466;6.686031174322154;0.002700424406568797;0.6321649570480018;[MAP3K3, FZR1]
GO:0060074;synapse maturation;4.0;1.0;0.75;9.628524252492122;25.433288066812054;7.697632086000634;8.512292631229848E-4;0.6436572628545723;[NFIA]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[NCKAP1, PARVG, VSIG1, TBC1D20, ITGB3, LST1, KIF14, NCKAP1L, THOC2, ECT2, EPHA1, SOX6]
GO:0086009;membrane repolarization;6.0;0.7586651285174919;0.7024528768488905;9.158520623246385;39.57817623486923;6.781341354126479;0.0013246459405349812;0.6699184248047958;[ATP1B2]
GO:0051252;regulation of RNA metabolic process;6.0;0.3741440593815082;0.5101923422808986;6.058991556010752;70.57719042479788;1.4852765226317355;0.002362155048170368;0.39907742302995336;[AHCYL1, MAML1, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, TIAL1, RPS6KA4, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, XRN1, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, ZC3HAV1, ZNF25, MTDH, FXR1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, SETDB1, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SOX30, SETX, STAG1, GOLGB1, PKIA, ZNF30, DCP1A, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, ATF7IP2, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, SMG5, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, HAVCR2, ZNF485, UPF1, TSC22D4, HELLS, SEC13, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, TOX4, GAL, NCOR1, MTF2, TFEC, MED20, DCP2, VGLL4, ARHGEF5, ZNF350, NEDD8, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, SERTAD2, UBN1, GPBP1L1, SCAND1, EXOSC3, ZNF462, EGLN2, YTHDF3, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, LIMS1, CRTC2, NCF1, NAB1, CD80, GMNN, ARID4A, CIB1, RORA, MSI2, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, ZBTB32, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, YTHDC1, MAX, RLF, SUPT6H, GTF2E2, STK3, CCNB1, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, UBE2I, WFS1, NONO, CNOT10, CLK4, CLK3, NFKB1, CLK1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, SON, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, CNOT8, ZNF532, ZNF410, NFE2L1, PHF19, USP36, CIITA, ONECUT2, YWHAB, ITGB2, DDX41, CHD1, AFF4, CKS1B, FLCN, LBH, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, TNPO1, RBM5, DACT1, KLF12, TBP, KLF13, PEG3, DTX3L, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, YWHAZ, DUSP22, CREB3, TFDP1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TFPT, PABPN1, U2AF2, RBBP5, TP53INP2, CCL5, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, WTAP, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TRIM32]
GO:2000001;regulation of DNA damage checkpoint;7.0;0.7866048967936545;0.7442218136540277;9.446202695698167;47.13716505022567;7.004484905440688;0.0015776384935366925;0.7091290490632969;[FEM1B]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[RAD51, TFDP1, TFDP2, MAX, CDC7, BRCA1, EZH2]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CREBBP, DNAJC7, BAG3, BAG1, EP300, IER5]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[FEN1, PNKP, MCM10, BRCA1, POLB, CHAF1B, CHAF1A, EXO1, UPF1, POLQ, RRM1, RFC3, RFC4, NCOA6, DONSON, WRNIP1, CDC7, BAZ1A, NFIA, NFIB, NFIC, POLE2, CDK2, CDK2AP1, MCM6, MCM2]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, LBH, FNTB, CTSH, SOX8, IL12A, ATP7A, SKP2, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, NME1, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, HBEGF, HDAC1, FOXG1, EBI3, DERL2, CRIP2, THBS1, CORO1A, RELA, CCNB1, FZR1, HLA-DMB, CCL5, NCKAP1L, CCL19, TBX1, MAP3K3, XBP1, CDC7, TSHR, CNOT6, CD4, IL6, SP1, CDK2, HLA-DPB1, KRAS, FAM98A, CNOT8, CCNJL]
GO:0080111;DNA demethylation;9.0;0.8653626801206646;0.8289219652406215;9.537552474286395;342.028404744498;6.781341354126479;0.011447382901218509;0.7430387373949403;[APOBEC3F, APOBEC3H, APOBEC3A]
GO:0071280;cellular response to copper ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.518977089658987;0.0026274528238337297;0.6565011041187423;[BECN1, MT1G, ATP7A, AQP1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, FLCN, NIPBL, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP1, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[SP3, ARNT, BPTF]
GO:0046878;positive regulation of saliva secretion;7.0;1.0;0.8509193652572005;9.628524252492122;141.10840522306705;8.67846133901236;0.004722771333496198;0.7947362817240173;[AQP1]
GO:0030007;cellular potassium ion homeostasis;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;285.76071857591336;7.138016298065211;0.009564154082785858;0.7612791106150483;[ATP1B2]
GO:0072488;ammonium transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.193206181234276;79.759283350777;7.069023426578259;0.002669471435055758;0.7124295520356204;[SLC25A20, RHD, AQP1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[PDGFRB, CDKN1A, CCNB1, SPHK1, FNTB, AQP1]
GO:0070345;negative regulation of fat cell proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;8.16763571524637;0.0021377902344145586;0.7408135829017477;[PER2, TFDP1]
GO:0035378;carbon dioxide transmembrane transport;7.0;1.0;0.8509193652572005;9.628524252492122;75.4531771037942;8.67846133901236;0.0025253499342132637;0.7947362817240173;[AQP1]
GO:0086064;cell communication by electrical coupling involved in cardiac conduction;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;22.009319849728328;7.138016298065211;7.366321282685284E-4;0.6150384854347593;[ATP1B2]
GO:0016458;gene silencing;7.0;0.6835726970475526;0.6927057137809769;8.659123695304018;69.21166146355857;4.8942717050940985;0.002316452022733967;0.6012126478626229;[HELLS, HDAC1, H3F3A, CNOT10, SUPT6H, SND1, SIRT2, CNOT6, HIST3H2A, CNOT1, CNOT3, CNOT8, SOX6]
GO:0070979;protein K11-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;6.375876246018314;0.00527474598481953;0.7584915600596062;[FZR1, UBE2B, UBE2T, CDC26, ANAPC5, ANAPC11, UBE2L3]
GO:0048708;astrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;7.004484905440688;7.746646556020492E-4;0.6484506956670166;[SOX6]
GO:0035377;transepithelial water transport;6.0;1.0;0.8231203125901445;9.628524252492122;37.816033014382604;9.083926447120524;0.0012656685927712316;0.7876727335416686;[AQP1]
GO:1903278;positive regulation of sodium ion export across plasma membrane;10.0;1.0;0.9152410118609203;9.628524252492122;363.3657930958667;8.390779266560578;0.012161526086936028;0.8443458537639685;[ATP1B2]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[MYL4, DNAJC7, DNAJB11, ATP1B2, DYNLL2]
GO:0040020;regulation of meiotic nuclear division;7.0;0.609056648853049;0.655447689683725;8.529911963824013;66.11398289201945;6.280566066213989;0.002212775508674272;0.6721078059595746;[FZR1, UBE2B, FBXO5, SIRT2]
GO:0085018;maintenance of symbiont-containing vacuole by host;6.0;1.0;0.8231203125901445;9.628524252492122;26.843536284103255;9.777073627680469;8.984290018147254E-4;0.8231203125901445;[AQP1]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[ARID4A, NCKAP1L, BPGM, SOX6]
GO:1901018;positive regulation of potassium ion transmembrane transporter activity;10.0;0.7671156992804218;0.7987988615011312;9.418803721510052;727.157729141708;6.7325511899570465;0.02433731479490395;0.7595439928109722;[GAL, NPPA, ATP1B2]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, FXR1, CENPF, XBP1, SOX6, VAMP5, HBEGF]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[MTPN, BAG3, ITGA2, NPPA, CASP2, TNFRSF10A, NFKB1, AQP1]
GO:0048791;calcium ion-regulated exocytosis of neurotransmitter;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;176.6280078189881;6.343086423195323;0.005911580466814719;0.7396267465268138;[RPH3A, SYT15, SYTL3]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, AQP1]
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;6.7325511899570465;0.010250602759086841;0.719302980950052;[HIST1H2BJ, RFFL]
GO:0010529;negative regulation of transposition;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;41.7579727432223;6.781341354126479;0.0013976017679800644;0.6370391240755715;[APOBEC3F, ZNF93, APOBEC3H, APOBEC3A]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[BCAR3, CDKN1A, NCF1, CCNH, ITGB3, CD80, KIF14, CIB1, PTPN22, IGF1R, CKS1B, RPS6KA4, FLCN, AKAP13, ARL6IP5, IL12A, HAVCR2, PDGFRB, FGA, DUSP5, FBXO18, KSR1, SPHK1, FGG, PLAUR, ZFP91, FLT3LG, OXSR1, SENP2, GFRA2, MAPK8IP3, ERN1, DUSP22, TWSG1, KARS, ALS2, IL23A, JTB, LCP2, ADNP, EPHA1, ARHGEF5, HBEGF, HDAC3, ROCK2, ITLN1, LRP8, THBS1, STK3, C3, RAP1B, PPP2CA, CCNB1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, TBX1, MAP3K3, PDE6H, CCL20, XRCC5, GPR55, TNFRSF10A, PILRB, CDK9, CENPE, CD4, IL6, CDK5, TAOK2, CDK2AP1, KRAS, CALM3, CAMK1, CALM1, CALM2, EZH2]
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;6.0;1.0;0.8231203125901445;9.628524252492122;27.942148572769092;7.212124270218933;9.351985664295021E-4;0.6919486831672181;[ATP1B2]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, CCL5, NCKAP1L, CCL19, CCR2, HSD3B7, FCER1G, CCL20, TNFRSF10A, ATP1B2, VAV1, NLRP12, IL6, COL1A2, SDC1, CD244, ARHGEF5]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[FGA, HIST1H2BJ, BCL3, ITLN1, DEFB1, RNASE3, HIST1H2BC]
GO:0071549;cellular response to dexamethasone stimulus;9.0;1.0;0.896240625180289;9.628524252492122;704.2721689024621;6.343086423195323;0.023571355689363423;0.7206263598461826;[ERRFI1, ABCC2, DDIT4, AQP1]
GO:0017158;regulation of calcium ion-dependent exocytosis;9.0;0.6799073451904818;0.73619429777553;8.730582659286164;63.43514412564899;5.514393750639154;0.0021231171859622203;0.6782469780335098;[RAP1B, RPH3A, TRIM9, CDK5, ATP2A2, SYT15, SYTL3, RAB3GAP1]
GO:0051438;regulation of ubiquitin-protein transferase activity;10.0;0.811012628672052;0.8207473261969463;9.466005322994347;92.40927421500034;5.788089581116195;0.0030928552450286634;0.7112441822128948;[FZR1, DTX3L, RPS7, FEM1B, FBXO5, MASTL, UBE2L3, MAD2L1]
GO:0010762;regulation of fibroblast migration;7.0;0.8259837884571596;0.7639112594857803;9.427853557029971;40.03709713961528;6.481236761676141;0.0013400056102148314;0.6823701146576509;[RFFL, MTA2, THBS1]
GO:0060442;branching involved in prostate gland morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;76.11227611542269;7.57984905034425;0.0025474093849818693;0.710754145523778;[SFRP1, FEM1B]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, RAB11A, AQP1]
GO:1903288;positive regulation of potassium ion import;10.0;1.0;0.9152410118609203;9.628524252492122;414.29394802332047;8.67846133901236;0.01386604559999416;0.8590579283277371;[ATP1B2]
GO:0003097;renal water transport;6.0;0.8933024483968273;0.7697715367885581;9.523163736834295;25.336377220787078;8.16763571524637;8.479857443206279E-4;0.7408135829017477;[AQP1]
GO:0006883;cellular sodium ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;285.76071857591336;6.8867018697843045;0.009564154082785858;0.7484268790654467;[ATP1B2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, HOXC4, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, NFIA, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, NFE2L1]
GO:0006884;cell volume homeostasis;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;49.534292112730455;6.444869117505266;0.0016578681790444336;0.6527112189764278;[CLCN3, AQP1]
GO:0010738;regulation of protein kinase A signaling;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;45.070113835906206;6.599019797332524;0.001508456149618737;0.6883935445785896;[AKAP11, AKAP7]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[VIL1, CSNK2A1, PLAUR, TNFRSF10A, NLRC4, RFFL, UBE2Z, THBS1, AQP1]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CDK2, AQP1]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[FZR1, BRCA1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, APOBEC3F, DTX3L, APOBEC3H, DDX41, ZC3HAV1, TMEM173, LYST, UNC13D, RELA, ITCH, ILF3, IL6, POLR3C, IL23A, POLR3E, DDIT4, NLRP3, SERINC3, APOBEC3A, EXOC1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[NPEPPS, SFRP1, CCNB1, TBL2, LMNA, UBQLN1, RORA, HYOU1, ATP7A, KCNK3, SIRT2, AQP1]
GO:0055007;cardiac muscle cell differentiation;6.0;0.7866048967936545;0.7164227609869718;9.0689084645567;45.916641199513585;6.409777797693995;0.0015367886586535107;0.6509166472493662;[AKAP13, RXRA, ARID1A, SOX6]
GO:0030500;regulation of bone mineralization;6.0;0.8259837884571596;0.7361122068187242;9.405380701177911;42.16292605820722;5.572381008289503;0.0014111551909982874;0.6080921364962873;[TFAP2A, ANKH]
GO:0032006;regulation of TOR signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;5.244474134527214;0.001508456149618737;0.6191220163899107;[FLCN, SEC13, HDAC3, SEH1L, DDIT4, CLEC16A, RFFL, FAM83D, ARNTL]
GO:0030185;nitric oxide transport;5.0;1.0;0.7902410118609202;9.628524252492122;43.442191728354636;8.67846133901236;0.0014539710617137646;0.7340579283277371;[AQP1]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[TFDP1, TFDP2, YWHAB, TP53BP2, BID, YWHAZ, BBC3]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[XBP1, EGLN2, CSNK2A1, ZFAND2A, EDEM1, ATPIF1, RAD23A, SIRT2, DDB1, ITCH, FZR1, GGA3, PSMC1, VPS11, UBQLN1, STX5, TRIM32, DACT1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[FZR1, MASTL]
GO:1901797;negative regulation of signal transduction by p53 class mediator;8.0;0.8259837884571596;0.7879918942285797;9.466005322994347;239.487551390376;6.409777797693995;0.008015432820232688;0.7027963346592216;[SENP2, RFFL]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[SFRP1, CLEC3B, SOX6, LIMS1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, PSMB5, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, MAD2L1]
GO:0071288;cellular response to mercury ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;9.083926447120524;0.002604253811492351;0.7876727335416686;[AQP1]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[RAP1B, IGFBP5, ITPR2, AQP1]
GO:2000726;negative regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;669.6541776470041;7.292166977892469;0.022412722676212672;0.769162383550154;[SOX6]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[CCNB1, FZR1, CDC26, BUB1B, ANAPC5, ANAPC11, MAD2L1]
GO:0010107;potassium ion import;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;6.063501560976162;0.004073929841064025;0.7253287636709003;[ATP1B2]
GO:0033326;cerebrospinal fluid secretion;6.0;1.0;0.8231203125901445;9.628524252492122;48.40223855199413;8.67846133901236;0.0016199793651486486;0.7669372290569613;[AQP1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, BRCA1, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, HIST1H2BC, HIST1H2BO, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3]
GO:0006182;cGMP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;6128.1106202320725;6.558197802812269;0.20510234751766956;0.7678154929528684;[NPPA, AQP1]
GO:2001271;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis;13.0;1.0;0.9625549647676366;9.628524252492122;947.5852765280836;8.67846133901236;0.03171482643401269;0.9063718812344532;[RFFL]
GO:0009972;cytidine deamination;11.0;1.0;0.9324289523296623;9.628524252492122;2918.4586051188953;7.474488534686424;0.09767818307110789;0.8146746435927894;[APOBEC3F, APOBEC3H, APOBEC3A]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[ITIH2, PRKCSH, SERPINA10, CCNF, NEDD8, COPS7A, MSLN, PSMB10, PSMA7, HSP90B1, PSMD8, C3, TGOLN2, PSMD7, PSMB5, PSMD4, RBBP5, PSMD2, UBD, PSMB1, SKP2, APOL1, FGA, KLHL25, IGFBP5, WFS1, FEM1B, RHBDD1, FGG, FBXL15, FBXL16, BTBD6, RAB11A, DDB1, IL6, SPSB1, COPS5, PSMA1, PSMC1, RAB13, STT3A, CALU, PSME2, FBXL3, ASB3]
GO:0060743;epithelial cell maturation involved in prostate gland development;5.0;1.0;0.7902410118609202;9.628524252492122;60.27643566366833;8.67846133901236;0.002017398056392783;0.7340579283277371;[FEM1B]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, SOX6, ZNF564, DACT1, TLE4, KLF12, PEG3, ZBTB32, ARID1A, SIRT2, DUSP22, EID1, BRMS1, NCOR1, TBL1XR1, CCNE1, MTF2, HOXB4, TIMELESS, LCOR, PPID, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, BPTF, IRX1, TFAP2A, DR1, CREBBP, UBE2I, WFS1, NFKB1, PER2, GFI1B, NFIA, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, EZH2]
GO:0071472;cellular response to salt stress;6.0;0.7763722522362496;0.7113064387082693;9.34084218004034;100.19865821471498;7.57984905034425;0.0033535589175086402;0.710754145523778;[XRCC5, AQP1]
GO:0070383;DNA cytosine deamination;9.0;1.0;0.896240625180289;9.628524252492122;166.36310735944548;7.57984905034425;0.005568023486244473;0.7838744581139225;[APOBEC3F, APOBEC3H, APOBEC3A]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, CNOT10, CNOT4, CNOT6, CCNB1, TFDP1, TFDP2, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[TFDP1, TFDP2, CCNE1, GFI1, FBXO5, E2F7]
GO:0071474;cellular hyperosmotic response;6.0;0.8933024483968273;0.7697715367885581;9.548481544818586;99.28236748284083;7.379178354882098;0.003322891491320933;0.7004918368257019;[ERRFI1, XRCC5, AQP1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[YY1, DDB1, CREBBP, CDKN1A, HIST3H2A, RHBDD1, TP53INP1, PBK, EP300, PPID, CDC25A, AQP1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1, IL6, ECT2, RELA, EZH2, AQP1]
GO:0070306;lens fiber cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[FZR1]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[ILF3, APOBEC3F, APOBEC3H, CCL5, ZC3HAV1, APOBEC3A]
GO:0016554;cytidine to uridine editing;9.0;1.0;0.896240625180289;9.628524252492122;133.9430579393504;7.292166977892469;0.0044829536083040925;0.769162383550154;[APOBEC3F, APOBEC3H, APOBEC3A]
GO:0030049;muscle filament sliding;6.0;1.0;0.8231203125901445;9.628524252492122;20.959081145343944;6.139487467954083;7.014815839862524E-4;0.6370939872166814;[MYL4, MYL6B]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, SYVN1, RFFL, TRIM32]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, FLI1, SOX30, STAG1, ZNF30, INTS4, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, INTS10, ATF7IP2, HOXC13, BRCA1, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, TFEC, MED20, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, CRTC2, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, ZNF532, ZNF410, NFE2L1, PHF19, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, MKL1, ARNT, SAFB, ARID1A, CREB3, TFDP1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:0046326;positive regulation of glucose import;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.68372616907679;5.970411137910149;0.0028342881044734467;0.6803271032452366;[ITLN1, ADIPOR2]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[GAK, TOR1A, DNAJC7, HSPA6, BAG1, HSPE1]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[NCKAP1, OXTR, DGKD, NCF1, MAML1, WIPF2, CD80, IL5RA, CIB1, PKD2L1, RORA, IGF1R, TIAL1, RPS6KA4, GNAT2, ADORA3, NPPA, CFL1, EP300, HOMER3, IL12A, TLE4, IFNAR2, SEMA6B, PDGFRB, LAG3, IL4R, CSNK2A1, FLT3LG, HLA-A, HLA-F, RUNX2, BCR, SFRP1, TWSG1, KARS, SLC9A6, CD8B, IL23A, CCNE1, DDIT4, ELMO1, PSME2, EPHA1, CSNK1G2, CSNK1G1, CD151, DIABLO, EBI3, DTX2, KLHL12, APCDD1, ADIPOR2, CORO1A, EFNA4, CRHR1, RASGRP4, IL22RA2, MTDH, HSP90B1, RAP1B, SGPL1, BAG3, TSPAN7, BAG1, TSPAN4, DVL3, NCKAP1L, TSPAN2, RIPK1, MARK2, HLA-DQA1, ATP6V1F, FAM83A, BBS2, EIF2B4, CREBBP, UBE2B, BTN2A1, EIF2AK3, IFT122, TNFRSF10A, PILRB, PILRA, NFKB1, SETX, VIL1, NFKBIA, IL6, COL1A2, ARPC2, PTPRA, FES, GNAQ, SDC1, CALM1, HLA-DRB3, CPEB4, CIITA, CDKN1A, SIGLEC9, ITGB4, ITGB3, ITGB2, ARPC1A, USP34, PTPN22, IL27, NUP62, CASP2, CTLA4, CCR2, DACT1, HLA-DPA1, ACTR2, FCER1G, CAMLG, PARP2, ITGA2, ROM1, PLAUR, PDCD1LG2, BTN3A2, SENP2, GFRA2, YWHAZ, SIRT2, VAV1, DDB1, ITPKB, DUSP22, IRF4, TAX1BP3, LCP2, LCP1, DAGLB, HBEGF, ROCK2, NOTCH2NL, NEDD9, LILRA2, LRP8, AKAP2, RELA, CLN3, GNG2, POLR2B, CCL5, PERP, MKNK2, IL21R, AP2S1, POLR2G, NCAM1, CSK, CCL19, BID, MAP3K3, CCL20, EYA2, CD70, G0S2, LILRB3, TSHR, ITCH, CD4, P2RX4, TNIP2, CENPJ, TSPAN17, HLA-DPB1, CD9, CCM2, MNDA, KRAS, LIMS1]
GO:0048864;stem cell development;4.0;0.8436909121759173;0.6718454560879586;9.34084218004034;32.15320660831846;6.375876246018314;0.001076138889173156;0.576062607729944;[SOX8, KLHL12, MSI2]
GO:0009624;response to nematode;5.0;1.0;0.7902410118609202;9.628524252492122;27.267803904038782;8.67846133901236;9.126288572378991E-4;0.7340579283277371;[ITLN1]
GO:0002026;regulation of the force of heart contraction;7.0;0.7192862368539868;0.710562483684194;8.763526815005518;26.867502833526505;6.444869117505266;8.992311406554274E-4;0.6805102716434839;[MYL4, ATP2A2]
GO:0006906;vesicle fusion;6.0;0.6799073451904818;0.6630739851853854;8.563813515499694;63.097974703971886;5.192106149009898;0.0021118324288514666;0.5886448625081389;[GOSR1, SYT15, STX11, SYTL3, TAPBP, RPH3A, RAB20, VPS41, VPS8, VPS11, STX5, SNAP29, SPG11, VAMP5, RAB8B, SEC22C]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, BRCA1, AATF, UBE2Z, IGF1R, AQP1, NUP62, CFL1, CASP2, CTSH, SOX8, IER3, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, HSP90B1, CLN3, BAG3, CCL5, LMNA, BAG1, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, XBP1, UBE2B, EYA2, WFS1, NONO, RHBDD1, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, TNIP2, BCL3, KRAS, ERCC5, HYOU1, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, NLRC4, ZC3HAV1, LILRA2, CORO1A, RELA, C2, C3, PRDX1, SLAMF7, NLRP3, CSK, APOL1, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3C, FES, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:2000741;positive regulation of mesenchymal stem cell differentiation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;146.28124190880965;8.390779266560578;0.00489590152211723;0.7800242071602487;[SOX6]
GO:0071466;cellular response to xenobiotic stimulus;4.0;0.7436939687323844;0.6218469843661922;8.578702127993445;40.79473292833871;5.769740442447999;0.0013653629982354628;0.5450647945471605;[ERRFI1, ABCC2, DDIT4, APOBEC3A, AQP1]
GO:0032332;positive regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;229.711107350086;6.832634648514029;0.007688224036432589;0.7003406189322132;[SOX6, RUNX2, RELA]
GO:0030950;establishment or maintenance of actin cytoskeleton polarity;6.0;1.0;0.8231203125901445;9.628524252492122;64.1120899346335;7.212124270218933;0.002145773952977257;0.6919486831672181;[AQP1]
GO:0030157;pancreatic juice secretion;6.0;1.0;0.8231203125901445;9.628524252492122;60.48885175748684;7.8311634786251565;0.0020245074318908153;0.7236063770733796;[COPA, AQP1]
